Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI
Launched by EVIDATION HEALTH · Jan 19, 2024
Trial Information
Current as of July 02, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Member of the Evidation platform
- • 18 years or older
- • Lives in the U.S.
- • Currently owns and uses a consumer wearable activity tracker (Apple Watch, Garmin, or Fitbit) linked to their Evidation account
- • Meets data density requirements for wearable data: Steps and heart rate data present for 15% of the last 60 days (or no fewer than 2 total days for Evidation accounts less than 60 days old)
- Exclusion Criteria:
- • Does not have an Evidation account
- • Not 18 years or older
- • Does not live in the U.S.
- • Does not have an activity tracker linked to their Evidation account
- • Enrolled in an Evidation supported ILI monitoring and engagement program, or clinical study (e.g., FluSmart)
About Evidation Health
Evidation Health is a pioneering clinical trial sponsor focused on harnessing real-world data to transform healthcare insights and improve patient outcomes. By integrating technology and analytics, Evidation leverages patient-generated data and digital health tools to conduct innovative clinical research, enabling more efficient trial designs and enhancing participant engagement. Committed to advancing precision medicine, Evidation collaborates with pharmaceutical companies, healthcare providers, and research institutions to facilitate evidence-based decision-making and accelerate the development of novel therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Mateo, California, United States
Patients applied
Trial Officials
Ernesto H.N. Ramirez, PhD
Principal Investigator
Evidation
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported